The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome

NCT03436303 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Menopause Syndrome

Interventions

DRUG: CEE 0.625 mg/MP 100mg
DRUG: CEE 0.3 mg/MP 100mg
DRUG: CEE 0.625mg/dydrogesterone

Sponsor

Peking Union Medical College Hospital